Pharmafile Logo
Pharmafocus logo
Advanced Search

Pfizer signs $43bn deal to buy Seagen

March 14, 2023
Sales and Marketing

Pharma giant Pfizer has signed a definitive merger agreement valued at $43bn to buy biotech firm Seagen.   US-based Seagen …

News

Scottish patients with the most aggressive form of viral hepatitis become first in UK to be offered routine NHS access to Hepcludex® (bulevirtide)

March 14, 2023
Business Services

Monday 13 March 2023, London, UK – Gilead Sciences Ltd today announced that the Scottish Medicines Consortium (SMC) has become …

News
Press release

Cingulate and Indegene Announce Joint Commercialization Agreement for Lead ADHD Candidate CTx-1301

March 13, 2023
Business Services

KANSAS CITY, KANSAS and PRINCETON, NEW JERSEY – March 13, 2023 – Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing …

News
Press release

BRITISH LAND AND AUSTRALIANSUPER ANNOUNCE LIFE SCIENCES AMBITION AT CANADA WATER

March 13, 2023
Business Services

13 March 2023

News
Press release

Calliditas Announces Primary Endpoint Successfully Met in Phase 3 NefIgArd Trial Evaluating Nefecon® in IgA Nephropathy

March 13, 2023
Business Services

Calliditas Therapeutics AB (Nasdaq: CALT, Nasdaq Stockholm: CALTX) (“Calliditas”) today announced positive topline results from the global, randomized, double-blind, placebo-controlled …

News
Press release

Richard Stedman rejoins ACG as the CEO of Engineering Division

March 13, 2023
Business Services

ACG, a leading supplier of integrated manufacturing solutions to the global pharmaceutical and nutraceutical industries, is pleased to announce that …

Appointment

Sanofi to acquire Provention Bio in $2.9bn deal

March 13, 2023
Sales and Marketing

Sanofi has agreed to acquire Provention Bio as part of a $2.9bn deal that aims to improve the company’s portfolio …

News

Gilead Sciences wins $175m in ongoing HIV fraud case

March 13, 2023
Sales and Marketing

Gilead Sciences, a research-based biopharmaceutical company, has won again in the lawsuit levelled against clinics, prescribers, medical labs and pharmacies …

News

Nasal spray that relieves migraines in minutes approved by FDA

March 13, 2023
Medical Communications

Pfizer is planning to launch a fast-acting nasal spray that can relieve pain from migraines in as little as 15 …

News

Horizon Therapeutics announces real-world treatment results for Dysthyroid Optic Neuropathy drug

March 13, 2023
Medical Communications

Biopharma company Horizon Therapeutics has announced real-world treatment results for its Thyroid Eye Disease (TED) drug in patients with Dysthyroid …

News

Biotech centre focusing on gene therapies opens in Bristol, UK

March 10, 2023
Medical Communications

A new state-of-the-art facility named the Clinical Biotechnology Centre (CBC) is opening in Bristol, UK. It cost approximately £10m to …

News

FDA makes unusual ‘misinformation’ comment on Lucira’s EUA for COVID-19 and flu test

March 10, 2023
Sales and Marketing

The FDA has made a rare comment about what happened at Lucira Health’s Emergency Use Authorization (EUA) filing for its …

News

Acadia Pharmaceuticals awaits FDA decision for first-of-its-kind Rett syndrome drug

March 10, 2023
Research and Development

Acadia Pharmaceuticals is aiming to follow in the footsteps of Reata Pharmaceuticals, who won approval for its novel drug to …

News

FDA committee supports Roche’s lymphoma treatment

March 10, 2023
Medical Communications

 A committee at the FDA have voted in favour of Roche’s Polivy antibody drug targeting untreated diffuse large B cell …

News

FlyPharma Europe, Vienna: 2023 conference officially launched

March 9, 2023
Business Services

FlyPharma Europe, Vienna: 2023 conference officially launched   FlyPharma Conferences is pleased to announce its seventh event in Europe, which …

News
Press release

MSD presents Phase 3 data for its Investigational Activin Signaling Inhibitor, in Adults with Pulmonary Arterial Hypertension on Background Therapy

March 9, 2023
Business Services

LONDON, UK, March 6, 2023 – MSD (tradename of Merck & Co., Inc., Rahway, N.J., USA (NYSE: MRK)) today announced …

News
Press release

GSK’s RSV vaccine ready to launch

March 9, 2023
Sales and Marketing

GSK has announced that it is ready to launch its respiratory syncytial virus (RSV) vaccine in the US at some …

News

Eli Lilly & Co’s Alzheimer’s disease drug fails to stop disease decline

March 9, 2023
Research and Development

Eli Lilly & Co have today announced that its Alzheimer’s disease (AD) hopeful did not slow the progression of cognitive …

News

AstraZeneca shares positive results from Imfinzi trial

March 9, 2023
Research and Development

Pharma giant AstraZeneca has shared positive results from a phase 3 trial on Imfinzi, its resectable non-small cell lung cancer …

News

Respiree gets FDA clearance for cardio-respiratory wearable

March 9, 2023
Medical Communications

Respiree, a digital therapeutics start-up, has secured the 510(k) FDA clearance for its RS001 cardio-respiratory wearable.   RS001 is a …

News
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026